The QualityStocks Daily Monday, August 13th, 2018

Today's Top 3 StockMarketWatch

BUYINS.NET (TIS) +195.07%

NetworkNewsWire (CIIX) +48.25%

MarketBeat (ICLD) +40.91%

The QualityStocks Daily Stock List

Innovus Pharmaceuticals, Inc. (INNV)

HotTopPennyStocks, PennyPickAlerts, PHUB News, Wall Street Mover, StockMarketQuote, Fortune Stock Alerts, Penny Stock Bets, StockMister, 1-2-3 Stock Alerts, DSR News, Penny Stock Hub, BUYINS.NET, Promotion Stock Secrets, TopPennyStockMovers, SeeThruEquityResearch, Penny Stock Circle, and OTPicks reported earlier on Innovus Pharmaceuticals, Inc. (INNV), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is a developing Over-The-Counter (OTC) consumer goods and specialty pharmaceutical enterprise. The Company engages in the commercialization, licensing, and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. Innovus Pharmaceuticals is based in San Diego, California. The Company lists on the OTCQB.

Innovus generates revenues from its lead products BTH® Testosterone Booster; BTH® Human Growth Agent; Zestra® for female arousal and EjectDelay® for premature ejaculation. The Company has an additional five marketed products. These include Sensum+® for the indication of decreased penile sensitivity; Zestra Glide®; Vesele® for promoting sexual health; RecalMax™ for promoting brain and cognitive health; Androferti® (in the U.S. and Canada) to support overall male reproductive health and sperm quality; BTH Vision Formula; BTH Blood Sugar, among others and eventually FlutiCare™ OTC for Allergic Rhinitis, if its Abbreviated New Drug Application (ANDA) receives approval by the FDA.

Last year, Innovus Pharmaceuticals launched AllerVarx™ in the U.S. AllerVarx™ is a clinically proven supplement, scientifically formulated for the relief of allergy symptoms. AllerVarx™, selling in Europe under the brand name Lertal®, is a product Innovus exclusively in-licensed for the U.S. and Canada from NTC s.r.l., which is an Italian company.

Innovus Pharmaceuticals has plans to enter the oncology supportive care OTC market with an exclusive license to two GRAS (Generally Recognized As Safe by the U.S. FDA)-listed compounds, thymol and carvacrol, for cachexia and muscle growth and repair, from the University of Iowa Research Foundation.

Innovus Pharmaceuticals announced in 2018 that the FDA cleared the Company’s GlucoGorx™ Glucose Monitoring Test Kit, which includes a glucose meter, test strips and lancet device (GlucoGorx™ Kit) under the 510(k) filing of its manufacturing partner, ACON Laboratories, Inc. Innovus will offer the GlucoGorx™ Kit, which will provide highly sensitive glucose level testing results within four seconds, to its customers who buy its GlucoGorx™ clinical glucose supplement.

Last month, Innovus Pharmaceuticals announced that it entered into a pilot program with the nationwide pharmaceutical chain CVS Pharmacy, Inc. (CVS), a subsidiary of CVS Health Corp (CVS), to sell Innovus’ product Androferti®. If successful, the CVS pilot program could lead to the national pharmacy stocking and selling Androferti® on a scalable level across the nation and could expand to add more Innovus products.

Last week, Innovus Pharmaceuticals announced the filing by the Company for regulatory approval in Canada for its Xyralid® Suppositories drug for the relief of hemorrhoidal swelling; Beyond Human® Testosterone to promote and maintain testosterone levels in men; and RecalMax™ for cognitive health and mental sharpness. The regulatory approval process for the three products could take up to 210 days for approval depending on the application.

In addition, last week, Innovus Pharmaceuticals announced that it entered into a purchase agreement with the nationwide retail store chain Showcase, a Canadian company, for its drug Apeaz®, for arthritis pain relief. Apeaz® will be available in Showcase’s 110 stores across the U.S. and Canada and on its www.ShopAtShowcase.com website beginning mid-August 2018. 

Innovus Pharmaceuticals, Inc. (INNV), closed Monday's trading session at $0.163025, up 3.18%, on 1,637,331 volume with 123 trades. The average volume for the last 60 days is 711,497 and the stock's 52-week low/high is $0.078/$0.21.

chart

Gopher Protocol, Inc. (GOPH)

Profitable Trader Authority, Wall Street Mover, PennyStockScholar, PennyTrader, OTCtipReporter and Integrity Solution IR reported on Gopher Protocol, Inc. (GOPH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Gopher Protocol, Inc. is developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology. The Company provides a mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional features. Its Integrated Circuit (IC), named GopherInsight™, and accompanied software, creates a private and secured network for sharing information and adapting to user preferences. The system is self-learning and always developing. OTCQB-listed, Gopher Protocol is headquartered in Santa Monica, California.

The Company is developing a real-time, heuristic based, mobile technology. Upon development, the mobile technology will consist of a smart microchip, mobile application software, and supporting software, which run on a server. The system envisions the creation of an international network. The heart of this system will be its advanced microchip that will be able to undergo installation in any mobile device.

Gopher Protocol’s expectation is that this will result in an internal, private network between all mobile devices using the device through providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and more mobile features.

Gopher Protocol has its licensed technology, the Guardian Patch. The Guardian Patch device was conceived as an offshoot of its microchip technology named GopherInsight™. The mobile tracking technology will track and protect anything one cares about, with or without GPS (Global Positioning System). The Guardian Patch is a stick-on tracking device.

Additionally, the Company has its "dDrone" technology. This technology utilizes Artificial Intelligence (AI) to create what is believed to be the world's first" Smart Drone." Gopher AI drone technology employs machine learning to give drones advanced flight capabilities.

Gopher Protocol is working to integrate its Guardian Patch radio technology within its digital coin Blockchain system. Recently, the Company was granted its Guardian Patch patent and filed a non-provisional patent for its cryptocurrency system. Gopher Protocol’s exclusive licensor filed a non-provisional patent encompassing a proprietary GRC Blockchain-Based Radio Generated Digital Currency as announced on June 19, 2018.

The GRC, designed to be a new generation of cryptocurrency, will be using the Guardian Patch System to perform transactions and operations. In this way, each Guardian Patch user will have the option to use the GRC when using the Guardian Patch.

Gopher Protocol is incorporating its gEYE security engine into its digital currency Technology Platform, the GRC. With Gopher technology, upon full development, the radio based coin will provide that each transaction, called a block, is recorded. The gEYE system goal will be to secure Gopher's gNET communication protocol. The gEYE includes multiple layers of security methods. This includes advanced encryption.

Gopher Protocol, Inc. (GOPH), closed Monday's trading session at $1.3175, down 6.56%, on 334,461 volume with 362 trades. The average volume for the last 60 days is 394,153 and the stock's 52-week low/high is $0.16/$4.85.

chart

MariMed, Inc. (MRMD)

Stockhouse, Investors Hub, Marketbeat, Proactive Investor, The Street, Insider Financial, OTC Markets, and Daily Marijuana Observer reported on MariMed, Inc. (MRMD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

MariMed, Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation and production centers and dispensaries. The Company provides turnkey solutions to cannabis cultivators, producers, and dispensaries. It specializes in solutions for securing and operating facilities, manufacturing and processing, dispensary, layouts, and designs, merchandising and sales.

MariMed is based in Newton, Massachusetts and the Company lists on the OTC Markets Group’s OTCQB. MariMed Inc. is one of the 17 top-performing public cannabis companies in the United States tracked on the U.S. Marijuana Index, (www.marijuanaindex.com).

MariMed is focusing solely on serving the fast growing $7 billion legal cannabis industry. Itis working to create precision dosed products to treat specific conditions. MariMed’s team has developed state-of-the-art and regulatory compliant facilities in many states. These facilities are replicable and scalable models of excellence in horticultural principals, cannabis production, product development, and dispensary operations.

Cannabis experts, MariMed specializes in supporting the development of high quality state-licensed, medical cannabis dispensaries and cultivation facilities. The Company provides a comprehensive range of consulting services in the medical cannabis industry. It uses a systematic approach, from the permit and application process, to on-time operational readiness.

MariMed’s services include application assistance, real estate and safe access, build-out and continuing consultation, business acceleration solutions, and physician and patient outreach. MariMed Advisors, Inc. has a portfolio of high-quality branded products, product development plans, product packaging, as well as product licensing opportunities.

In 2017, MariMed announced the purchase of a 137,500 sq. ft. industrial building on 17 acres at 167 John Vertente Blvd., in the New Bedford, Massachusetts industrial park. It will develop approximately 70,000 sq. ft. into a full service, state-of-the-art medical cannabis cultivation and production facility. This has been leased to ARL Healthcare, Inc. (ARL), a Massachusetts not for profit corporation.

Recently, MariMed announced it acquired iRollie LLC. This includes its intellectual property (IP), clients, and its host of products and services. MariMed acquired iRollie and its executives in exchange for $600,000 in MariMed stock.

MariMed hired iRollie’s cofounders Mr. Luke Shepter and Mr. Joe Khoury to expand the iRollie business and to bring their expertise and services in house to support MariMed brands and clients.

Earlier this month, MariMed announced that it signed an exclusive worldwide licensing agreement with Vitiprints™ for the global production and distribution rights in all existing and future legal cannabis markets. This agreement extends to all cannabis products made using Vitiprints’ proprietary technology. This includes liquid ingredient formulation, printing process, and the resulting collection of dissolvable products.

MariMed expects to complete test marketing of the dissolvable product sets in a MariMed-managed facility within 90 days. Subsequently, it will launch in legal states across the nation. It will then expand internationally by way of sublicense agreements with qualified manufacturers and distributors. Products will be available on shelves as early as the end of Q4 2018.

MariMed, Inc. (MRMD), closed Monday's trading session at $2.5975, down 5.20%, on 192,995 volume with 414 trades. The average volume for the last 60 days is 396,888 and the stock's 52-week low/high is $0.201/$4.07.

chart

OptimizeRx Corp. (OPRX)

Marketbeat.com, Streetwise Reports, and Bull in Advantage reported on OptimizeRx Corp. (OPRX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OptimizeRx Corp. is the nation’s foremost provider of digital health messaging for the pharmaceutical industry. OptimizeRx is the leading aggregator of pharmaceutical-sponsored services in electronic health record (EHR) platforms. A health technology software company, OptimizeRx is based in Rochester, Michigan. The Company lists on the OTCQB.

OptimizeRx’s core product is a novel patient financial support software application. It replaces traditional physical drug samples through automating the process of distributing coupons and vouchers into healthcare providers’ eRx workflow, then automatically delivering them electronically to the pharmacy.

It promotes patients’ savings and support from the world's largest pharmaceutical companies. These include Pfizer, Lilly, Novartis, AstraZeneca, and many others.

The application replaces drug samples with electronic trial vouchers and co-pay coupon savings. These are electronically added to an e-Prescription and sent electronically to the pharmacy and are integrated within top Electronic Health Record (EHR) platforms in the country. These include Allscripts, Amazing Charts and Quest.

OptimizeRx also launched its OPTIMZEHR™. This is its consulting and implementation practice to assist pharmaceutical-biotechnology companies and healthcare provider platforms in determining and executing on mutually beneficial opportunities to jointly assist physicians and patients within their EHR workflow.

The Company has a group of services that integrate complete brand support into the EHR. This leads to enhanced patient care and improved outcomes. The offerings include Brand Messaging and Brand Support. OptimizeRx’s core product has been financial messaging, providing physicians with electronic coupons, co-pay offers, and vouchers for their patients at the point of care (PoC).

OptimizeRx has directly integrated its financing messaging with Amazing Charts, a top EHR and subsidiary of Harris Healthcare, to help patients save money and be better educated about prescriptions. OptimizeRx services will operate seamlessly within the Amazing Charts EHR workflow and alert health care providers (HCPs) to prescription savings and support information for patients.

Amazing Charts provides EHR, practice management, and other Health IT solutions. These have been adopted by more than 11,000 clinicians in more than 7,500 private practices.

This past January, OptimizeRx announced that it expanded its partnership with Allscripts Healthcare (MDRX). This partnership now includes an array of real-time messaging to Allscripts ambulatory platforms. This agreement includes financial, informational, as well as clinical messaging delivered at the point-of-care (PoC) via Allscripts ePrescribe™, Allscripts Professional EHR™ and Allscripts TouchWorks® EHR solutions.

Allscripts’ industry leading electronic health record (EHR) and ePrescribing (eRx) network totals over 180,000 physicians across 45,000 ambulatory facilities, 2,500 hospitals, and 17,000 post-acute organizations.

Last month, OptimizeRx announced that it gained access to the electronic health record (EHR) system of NextGen Healthcare. NextGen is a top five EHR and a unit of Quality Systems. OptimizeRx services will operate within the NextGen Healthcare EHR workflow and notify healthcare providers (HCPs) in real-time of potential prescription savings and support information for their patients.

For Q4 2017 and Full Year 2017, OptimizeRx’s Net Revenue was up 75 percent to a record $4.0 million in Q4, and up 56 percent to a record $12.1 million for the year. Net Loss for Q4 2017 was $0.2 million or $(0.01) per share, versus a Net Loss of $0.4 million or $(0.01) per share in Q4 2016. The improvement in Net Loss was mainly because of the increase in Revenue and decrease in Operating Expense as a percentage of Revenue.

OptimizeRx Corp. (OPRX), closed Monday's trading session at $12.49, up 0.73%. The average volume for the last 60 days is 10,274 and the stock's 52-week low/high is $2.49/$10.36.

chart

Strategic Environmental & Energy Resources, Inc. (SENR)

Streetwise Reports and Marketbeat.com reported on Strategic Environmental & Energy Resources, Inc. (SENR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Strategic Environmental & Energy Resources, Inc. (SENR) is a provider of environmental, renewable fuels and industrial waste stream management services. It has three wholly-owned operating subsidiaries. These are REGS, LLC; MV Technologies, LLC, and SEER Environmental Materials, LLC. SENR works for either destroying/minimizing hazardous waste streams more safely and at lesser cost than any competitive alternative, and/or processing the waste for use as a renewable fuel for the benefit of customers and the environment. SENR has its corporate office in Golden, Colorado.

The Company is strategically shifting to a dedicated environmental technology enterprise. It also has two majority-owned subsidiaries. These are Paragon Waste Solutions, LLC; and ReaCH4biogas (Reach).

SENR provides environmental, renewable fuels, and industrial waste stream management services to oil producers and refiners, railcar operators, industrial and manufacturing companies, medical facilities, government agencies, universities and environmental consulting firms. Its customers engage the Company to manage initiatives ranging from improving operating efficiencies to EPA (Environmental Protection Agency) compliance to creation of renewable fuels.

Fundamentally, SENR identifies, secures, and commercializes patented and proprietary environmental clean technologies in several multibillion dollar sectors. These sectors include oil & gas, renewable fuels, and all types of waste management, solid and gaseous.

Concerning Waste Destruction, the Company’s Paragon Waste Solutions is at the technological front line of the waste management and destruction industry. Paragon Waste Solutions’ patent-pending CoronaLux™ system uses a low-energy, plasma-enhanced pyrolytic process to safely and reliably destroy hazardous, chemical, biological (military de-weaponization), pharmaceutical, and regulated medical waste.

Pertaining to Industrial/Environmental solutions, SENR’s solutions portfolio includes services for environmental regulation and compliance, upstream/downstream oil and gas operations, wastewater treatment, dewatering/centrifuging, railcar and tank cleaning, and general waste handling and minimization services.

Regarding Odor/Emissions Control & Renewable Fuels, SENR’s MV Technologies is an engineering/technology business. MV designs and provides odor, vapor, and emission control systems for various sectors.

This past November, SENR announced that its majority-owned subsidiary, Paragon Waste Solutions, in association with its California partner, received final air quality permit approval from South Coast Air Quality Management District 'SCAQMD' in California for its CoronaLux Waste Destruction System.

In December, SENR announced that its majority-owned subsidiary, Paragon Waste Solutions, closed its joint venture (JV) agreement with GulfWest Waste Solutions. The new entity will be named Paragon Southwest Medical Waste, LLC (PSMW). It will have an exclusive license to the CoronaLux™ technology in a six-state area of the Southern U.S.

Paragon Waste Solutions will also be the operating partner for the business and sell several additional systems to the JV over the next five years. GulfWest Waste Solutions is owner and operator of one of the nation's few permitted medical waste incinerators located in Anahuac, Texas.

Last week, SENR announced that Paragon Waste Solutions completed the commissioning and start-up of Paragon Southwest Medical Waste, LLC (PSMW), a waste destruction facility in Anahuac, Texas. The initial loads of medical waste have been processed.

The facility now represents the first-time "bypass" medical waste can be destroyed in the U.S. on a large-scale, commercial basis in a way other than traditional incineration. PSMW is already permitted to be much larger than SENR’S present JV facility in Southern California.

Strategic Environmental & Energy Resources, Inc. (SENR), closed Monday's trading session at $0.1901, up 0.05%, on 1,600 volume with 3 trades. The average volume for the last 60 days is 19,952 and the stock's 52-week low/high is $0.161/$0.79.

chart

MassRoots, Inc. (MSRT)

Wealth Daily, Cannabis Financial Network News, Promotion Stock Secrets, Stock Commander, Stock News Now, OTCtipReporter, StockRockandRoll, PennyStockScholar, Profitable Trader Authority, SmallCapVoice, Penny Stock 101, CFN Media Group, Damn Good Penny Picks, Penny Picks, and OTCJournal reported on MassRoots, Inc. (MSRT), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

MassRoots, Inc. is a foremost technology platform for medical cannabis patients and businesses. Individuals use its application to share their cannabis experiences and stay connected with local dispensaries. MassRoots has affiliations with the top organizations in the cannabis industry. These include the ArcView Group and the National Cannabis Industry Association. Listed on the OTC Markets Group’s OTCQB, MassRoots is based in Denver, Colorado.

Businesses can use MassRoots to advertise their goods and services to cannabis consumers. MassRoots begins adding in features. These include order ahead, delivery, and the in-app purchase of ancillary products as regulations allow. MassRoots has about 300-plus dispensaries actively posting on its network.

The Company’s product pipeline includes Dispensary Finder & Menus; Product Pages & Reviews; Sponsored Posts 2.0; and Enhanced Profiles. Most of MassRoots’ advertising revenue has come from dispensaries and cannabis-brands in the States of California and Colorado.

MassRoots acquired DDDigtal, d.b.a. "Whaxy” in January of 2017. This is an online order-ahead and menu management platform. MassRoots has made a strategic investment in High Times Holding Corporation, "High Times", the foremost voice of the Cannabis Industry.

In addition, MassRoots acquired Odava, Inc. MassRoots now offers dispensaries a complete set of software to manage their regulatory compliance, streamline their supply chain, and develop successful consumer loyalty programs. Odava is a leading compliance and point-of-sale (POS) system for the cannabis industry.

MassRoots has created MassRoots Blockchain Technologies, Inc. This is a wholly-owned subsidiary of MassRoots dedicated to developing blockchain-based solutions for the cannabis industry.

MassRoots also acquired CannaRegs, Inc. CannaRegs is a foremost technology platform. It tracks changes in cannabis regulations and taxation at the municipal, state, as well as federal levels.

In June, MassRoots announced that it launched its revamped dispensary website, MassRoots for Business, accessible at business.massroots.com. Via this business site, dispensaries can list locations on the Company’s dispensary finder, update important information in real-time, and view insightful analytics on their local cannabis market.

MassRoots will host a shareholder update call on Tuesday, August 14, 2018 at 4:20 pm ET. During the call, Company Management will provide an update on the launch of its dispensary website, insight on recent and imminent developments at the Company and important milestones for Q4 of 2018.

MassRoots, Inc. (MSRT), closed Monday's trading session at $0.124, even for the day, on 1,459,256 volume with 240 trades. The average volume for the last 60 days is 854,627 and the stock's 52-week low/high is $0.11/$1.17.

chart

Voip-Pal.com, Inc. (VPLM)

SmallCapVoice, VC Stock Marketing, Clutch Investments, equities Canada, TryBestPennyStocks, SmallCapAllStars, FeedBlitz, TheSUBWAY, Stock Twiter, Pumps and Dumps, Equities, UndiscoveredEquities, and Buzz Stocks reported on Voip-Pal.com, Inc. (VPLM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Voip-Pal.com, Inc. owns a portfolio of patents relating to Voice-over-Internet Protocol (VoIP) technology. The Company is presently looking to monetize its fundamental patents through a sale or licensure of its technology. In December 1997, Voip-Pal.com incorporated in the State of Nevada. In 2013, it acquired Digifonica International (DIL) Limited to fund, co-develop, and complete Digifonica's patent collection. OTCQB-listed, Voip-Pal.com is based in Bellevue, Washington.

The Company’s patented technology provides Universal numbering ubiquity; network value as defined by Metcalfe; the imperative of interconnect, termination, and recompense for delivery of calls by other networks; and regulatory compliance in regulated markets. In addition, Voip-Pal’s patented technology provides interconnection of VoIP networks to mobile and fixed networks; and maintenance of uninterrupted VoIP calls across fixed, mobile, as well as Wi-Fi networks.

Voip-Pal believes that its Lawful Intercept patents could prove to be an important tool for law enforcement in its efforts to battle crime and stop terror attacks. The technology provides the means for judicially authorized covert intercept of any type of communications sent through VoIP. This includes voice calls, media, and messaging.

The Company’s Intellectual Property (IP) value comes from numerous issued US Patent and Trademark Office (USPTO) patents. This includes five parent patents, one of which is foundational and the others that build upon the former. The five core patents are: Routing, Billing & Rating (RBR); Lawful Intercept; Enhanced E-911; Mobile Gateway; and Uninterrupted Transmission.

Voip-Pal recently announced that it was issued U.S. Patent No. 9,948,549. Voip-Pal now owns 17 issued U.S. patents and three allowed U.S. patent applications.

Last month, Voip-Pal announced that it is the subject of two recent articles appearing in two well-respected business publications - IPWatchdog.com, and Flynn’s Harp, written by Mr. Mike Flynn, former editor and publisher of the Puget Sound Business Journal. Both articles have been posted in the news section of the Voip-Pal website www.voip-pal.com.

Voip-Pal.com, Inc. (VPLM), closed Monday's trading session at $0.08, up 3.90%, on 1,225,445 volume with 78 trades. The average volume for the last 60 days is 524,295 and the stock's 52-week low/high is $0.0125/$0.45.

chart

FISION Corp. (FSSN)

TradingView and MarketWatch reported on FISION Corp. (FSSN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FISION Corp. is a cloud-based digital asset management and marketing automation company based in Minneapolis, Minnesota. It serves enterprise clients in the health care, hospitality, financial/insurance, software, and technology industries. FISION has more than 65,000 users in 21 countries. FISION is an effective sales enablement and marketing asset management tool. Established in 2011, FISION lists on the OTCQB.

The Company’s solutions include simplified brand distribution, sales enablement, distributed & localized marketing, digital asset management, channel support, and measurement & analytics. FISION equips marketing and sales teams with a comprehensive set of enablement capabilities built to solve distributed marketing challenges.

FISION maximizes the brand potential of every sales interaction. Its advanced, proprietary technology specializes in managing customers’ brand and marketing content. This enables marketing and sales people to quickly and easily create compelling, personalized, on-brand communications that drive revenue and profits.

The Company’s centralized, cloud-based library supports close to 200 different file types. It gives a client total control over how company assets are stored, retrieved, and used.

FISION completed the acquisition of Volerro Corporation (Minneapolis, Minnesota-headquartered) following the announcement of a definitive purchase agreement on April 25, 2017. Volerro is a leader in cloud-based content collaboration and agile marketing technology. Volerro enhances the FISION platform with complementary cloud-based collaboration, agile marketing, and sales enablement software.

Volerro’s SaaS platform simplifies how enterprise teams create, refine, and distribute content. Volerro’s ReVu.Me cloud app allows team members to work on the same document in real-time with integrated chat and voice conferencing.

FISION’s patented platform’s unique multi-tiered and multi-tenant functionality permits outside agencies and other marketing partners to securely access a company’s content repository, as well as create collateral materials that stay true to approved branding and messaging.

Last month, FISION announced that it deployed its cloud-based digital asset management and agile marketing solution for a Fortune 500 financial services company. This company has over 20,000 employees and advisors across the nation managing greater than $700 billion in assets.

In addition, FISION provided an innovative integration with the client’s new event planning platform. This delivers an even deeper level of capabilities and benefits with its patented digital asset management technology.

This month, FISION announced that it deployed its cloud-based digital asset management and sales enablement platform for Medici, a fast-growing software company that is transforming the way doctors and patients interact. Medici enables users to text or video chat with their existing medical providers, including primary care physicians, pediatricians, specialists, therapists, veterinarians, dentists and more, via a HIPAA-compliant app.

Mr. Mike Brown, FISION’s Chief Executive Officer, said, “FISION’s core competency is our ability to manage, control, and distribute digital content, which is why Medici chose our platform. Medici now has a scalable solution, so as they grow and the rate of doctor inquiries increase, Medici staff can spend less time searching for documents and more time delivering the best in patient care.”

FISION Corp. (FSSN), closed Monday's trading session at $0.1795, up 8.79%, on 471,742 volume with 85 trades. The average volume for the last 60 days is 191,696 and the stock's 52-week low/high is $0.0811/$0.26.

chart

Lixte Biotechnology Holdings, Inc. (LIXT)

Stockhouse, 4-Traders, Real Pennies, MarketWatch, InvestorsHub, and Simply Wall St reported on Lixte Biotechnology Holdings, Inc. (LIXT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. is a drug discovery company based in East Setauket, New York. The clinical-stage Company utilizes biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. Lixte’s product pipeline encompasses two major categories of compounds at different stages of pre-clinical and clinical development that the Company believes have wide-ranging therapeutic potential for cancer and other debilitating and life-threatening diseases. Lixte Biotechnology lists on the OTCQB.

The Company’s cancer drug development strategy has led to the discovery of novel compounds. These have the potential to be therapeutically useful against several other important but seemingly dissimilar diseases.

The phosphatase inhibitors are in pre-clinical development for lessening the extent of tissue damage following stroke, heart attack, and septic shock. The deacetylase inhibitors are in pre-clinical development for the prevention and treatment of neurodegenerative diseases, traumatic brain injury, and topically for fungal dermatitis.

Lixte’s commitment is to discovering drugs for more effective treatments for cancer. It has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models.

The Company’s current drug portfolio includes inhibitors of protein phosphatases, which are vital to cell division and DNA damage repair, and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.

Lixte Biotechnology’s unique phosphatase inhibitor is LB-100, its lead compound. LB-100 is in a Phase I clinical trial at two NCI designated Comprehensive Cancer Centers and three U.S. Oncology Research locations.

Lixte Biotechnology granted an exclusive license of its LB-100 for the treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). LB-100 is not currently approved for treatment of HCC.

Under the license, Taipei Medical University will ascertain the effectiveness of LB-100 against HCC in clinical trials conducted in compliance with Taiwanese and U.S. regulatory requirements. TMU will pay milestone and royalty payments to Lixte Biotechnology.

In February, Lixte Biotechnology Holdings noted that investigators at the Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, reported on February 7, 2018 (Lai et al., Sci. Transl. Med.10, eaan8735 (2018)) that in animal models the Company’s protein phosphatase 2A (PP2A) inhibitors overcome resistance of chronic myelogenous leukemia (CML) cells to standard treatment.

Dr. John S. Kovach, Lixte Biotechnology Holdings’ Chief Executive Officer, said "The vast majority of CML cells are killed by drugs called tyrosine kinase inhibitors (TKI), the prototype of which is imatinib (Gleevec), considered the first truly targeted form of chemotherapy. … The Terry Fox investigators found inhibition of PP2A with LB-100 or LB-102 preferentially sensitizes these resistant CML cells to killing by TKI compared to normal bone marrow stem cells. If these results can be replicated in the clinic, LB-100 and analogs may further improve the effectiveness of CML therapy.”

Lixte Biotechnology Holdings, Inc. (LIXT), closed Monday's trading session at $0.35, up 4.01%, on 31,900 volume with 6 trades. The average volume for the last 60 days is 12,299 and the stock's 52-week low/high is $0.094/$0.45.

chart

Nippon Dragon Resources, Inc. (RCCMF)

Stock Gumshoe, OTC Markets Group, InvestorPlace, Stockhouse, Talk Markets, Streetwise Reports, and 4-Traders reported previously on Nippon Dragon Resources, Inc. (RCCMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Nippon Dragon Resources, Inc. is a hybrid mining & technology enterprise. The Company has high potential and advanced stage mining assets combined with a unique and exclusive green mining method. Nippon is active in the exploration and development of gold resources in the Province of Quebec. OTCQB-listed, Nippon Dragon Resources has its corporate office in Brossard, Quebec.

Nippon has its Thermal Fragmentation mining method. This is a mining method that uses heat to 'spall' high-grade veins, considerably decreasing the use of explosives. The method only extracts the mineralized ore with minimal dilution. The extraction process permits thermal fragmentation with an accuracy of 2 cm to rapidly extract any type of hard rock up to 110 cm wide.

With this precision, high grade precious and base metal veins can undergo extraction without dilution. The thermal unit can be set up to extract a specific corridor. Thermal Fragmentation could be utilized as a stand-alone method or as a first-rate complement to any conventional hard rock mining operation.

Nippon’s flagship gold property is Rocmec 1. This is a fully permitted project in Quebec. The project includes a 100-meter deep, two-compartment shaft, and an 844 meters’ decline, allowing access to four levels (50, 90, 110 and 130 meters).

The Company also has its Courville-Maruska exploration property in Courville Township, about 32 kilometers’ northeast of Val-d'Or, Quebec. The property comprises 20 mining claims encompassing an area of roughly 800 hectares. The property is on a gold-bearing quartz vein system.

Furthermore, Nippon has its Denain Project. This project covers two contiguous mining properties (Venpar and Vauquelin) totaling 24 mining titles. The Denain Project is around 60 km east of Val d'Or, Quebec.

Nippon Dragon Resources has a strategic partnership agreement with Val d’Or Resources (VOR). The partnership agreement will enhance Nippon Dragon’s position as an industry leader with its exclusive and patented Thermal Fragmentation technology. Via the creation of a new entity, Rocmec Gold, Inc., the new partnership is expected to substantially expand Nippon Dragon’s reach within Canada and other important markets.

Recently, Nippon Dragon Resources announced that following the sale of a thermal fragmentation unit to its client, Metalfer Mining D.O.O, the Unit was shipped, received, inspected by border authorities and released to the client.

In June, Nippon’s technical team started its customary four week orientation, training and implementation programme of its thermal fragmentation mining method at Metalfer’s mining site in Majdan Mountain district of Serbia.

Metalfer chose four of its employees with mechanical and heavy equipment experience to be trained to operate the Unit. This training programme covers all elements related to safety issues, hands-on instructions, operational usage, production and servicing of the Unit.

Nippon Dragon Resources, Inc. (RCCMF), closed Monday's trading session at $0.0178, down 36.43%, on 8,049 volume with 5 trades. The average volume for the last 60 days is 11,871 and the stock's 52-week low/high is $0.013/$0.056.

chart

Newgioco Group, Inc. (NWGI)

OTC Markets, TradingView, MarketWatch, and LAST10K.com reported on Newgioco Group, Inc. (NWGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Newgioco Group, Inc. is a betting software technology business. The Company provides regulated leisure lottery and gaming products and services by way of licensed subsidiaries based in Europe. Newgioco Group, together with its wholly-owned subsidiaries, is a fully-licensed and integrated gaming software technology enterprise.

Listed on the OTCQB, Newgioco Group has its headquarters in Toronto, Ontario. The Company also has an office in Rome, Italy. The Company was previously known as Empire Global Corp. It changed its name to Newgioco Group, Inc. in July of 2016.

Newgioco Group conducts its business chiefly through retail neighborhood betting shops and an internet-based gambling and sports betting software platform under the registered brand Newgioco, through its licensed website www.newgioco.it located in Italy.

The Company has acquired Multigioco Srl. This is a licensed gaming operator headquartered in Rome. Newgioco Group’s plan is to aggressively go after attractively priced, fragmented, and profitable gaming operators in Italy. Its goal is to become a top-tier gaming operator over a five-year investment time horizon.

Newgioco provides its clients a comprehensive set of leisure gaming products and services. These include sports betting, virtual sports, online casino, poker, bingo, lottery, interactive games and slots, and an innovative betting platform providing Business-to-Business (B2B) and Business-to-Consumer (B2C) bet processing.

In late January, Newgioco Group announced the signing of four new online gaming operators. This further expands Newgioco's distribution network in Italy.

The four new web skins include www.clubgames.it (Region: Sardegna/Lazio); www.mixbet.it (Region: Campania/Puglia); www.imperialbet.it (Region:Sicilia); and www.quibet.it (Region: Calabria).

The new operators expand Newgioco Group’s fast-growing online distribution to regions not earlier covered by the Company’s webshop locations. This brings the total retail stores to about 1,300. In addition, it increases the number of websites distributing the Newgioco brands to eight.

In February, Newgioco Group announced the launch of NG PAY payment gateway under a licensing agreement with Euronet Worldwide, Inc. headquartered in Leawood, Kansas. The Company's secure payment gateway by way of Euronet will be available on the www.ngpay.it website. It will make a broad assortment of integrated payment, pre-paid, remittance and reload solutions available to its registered online customers, partners, webshops, and retail stores.

Newgioco Group reported strong transactions growth for Q4 2017. It reported that sport betting volumes in Q4 2017 increased 25 percent on a year-over-year basis to $32 million. Gross gaming profits were $6.5 million in Q4. This is the highest for any quarter in Newgioco’s history. Gross gaming profits increased 82 percent on a year-over-year basis.

Newgioco Group, Inc. (NWGI), closed Monday's trading session at $0.44, down 0.23%, on 130,600 volume with 14 trades. The average volume for the last 60 days is 79,370 and the stock's 52-week low/high is $0.085/$1.78.

chart

ReelTime Rentals, Inc. (RLTR)

MarketWatch, Stockhouse, Marketwired, WalletInvestor, Penny Stock Hub, Barchart, Simply Wall St, Penny Stock Tweets, 4-Traders, InvestorsHub, and OTC Markets reported on ReelTime Rentals, Inc. (RLTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ReelTime Rentals, Inc. (d/b/a ReelTime VR, ReelTime Media Group) is a multimedia publishing business. The Company engages in helping individuals that have been thrust into the public eye to monetize their exposure and control the portrayal of their story. In addition, it develops, produces, and distributes Virtual Reality (VR) Content and technologies under the brand ReelTime VR.  ReelTime is headquartered in Seattle, Washington and lists on the OTC Markets.

ReelTime has end to end production, editing, and distribution capabilities for internal and external projects. At present, the Company produces three ongoing series for the Samsung Gear VR platform, VeeR TV, Oculus. It distributes them over manifold VR delivery sites.

Regarding Partnerships, ReelTime partners with other top VR distributors, content producers, and technology providers. Furthermore, concerning its Services, the Company offers Consulting, Production, Monetization, VR Set Design, VR Media Campaigns, as well as VR Content Production.

Pertaining to VR Set Design, ReelTime has a totally-dressed virtual set in its studio facilities. It can create any look one wants for their Virtual Reality show. Also, it can provide traditional virtual set backdrops.

Concerning VR Content Production, ReelTime has a team of editors and other pre/post-production professionals available for all elements of producing VR content. This is from the initial design concepts, to pixel-perfect deliverables.

ReelTime VR announced recently that it became the first to utilize a proprietary technology developed by the Company that allows it to film in full 360 x 360 Virtual Reality formats and simultaneously film in formats compatible with traditional Television platforms. This will allow ReelTime VRs shows the Company produces to not only be available on the rapidly growing premium VR sites it is currently available on, but it will additionally be available for distribution over mainstream Network Television formats and worldwide.

ReelTime has received patent-pending status from the United States Patent and Trademark Office (USPTO) for its non-provisional patent application encompassing apparatus and method claims for technology involving simultaneous capturing of 360 X 360-degree Spherical Panorama Images and Video. The technology will enable any cell phone or other camera to promptly capture 360 X 360 Virtual Reality Video or pictures without any need for stitching.

The VR content is compatible with and can be shared through 360 capable social sites in real time, and on any professional VR platform such as Oculas, Gear VR, Veer VR, Playstation VR, Littlstar, and the HTC Vive.

ReelTime will start using this inventive technology in its production of its award-winning Virtual Reality travel series “In Front of View”. The series commenced filming its second season in Thailand in July. It is shot in English and in Thai. Moreover, ReelTime VR is entertaining licensing agreements with select other VR, film, and TV producers to allow them to also gain a competitive advantage.

ReelTime Rentals, Inc. (RLTR), closed Monday's trading session at $0.018, even for the day, on 128,007 volume with 17 trades. The average volume for the last 60 days is 95,422 and the stock's 52-week low/high is $0.001/$0.08.

chart

International Frontier Resources Corporation (IFRTF)

MarketWatch, Stockhouse, Marketwired, 4-Traders, and Emerging Growth reported on International Frontier Resources Corporation (IFRTF), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

International Frontier Resources Corporation has a demonstrated record of accomplishment advancing oil and gas projects. The Company, by way of its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico. International Frontier Resources is based in Calgary, Alberta and the Company’s shares trade on the OTC Markets Group’s OTCQB.

International Frontier Resources (IFR) has projects in Canada and the United States, including the Northwest Territories and the State of Montana. In 2015, IFR created a JV company - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies. IFR and Grupo Idesa are fully aligned; each owns a 50 percent share in Tonalli.

An industry-leading JV combines the strength of Grupo Idesa and IFR. Grupo Idesa is a well-established Mexican petrochemical company. In addition, IFR brings proven Canadian expertise to Mexico.

Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators in Mexico and provides important insights into future rounds. Tecolutla is a very underdeveloped mature field with considerable upside potential.

Tonalli has submitted the regulatory applications and documentation, which will permit IFR to proceed with the drilling permit and operations at Tecolutla. The Tecolutla Block is in the Tampico-Misantla Basin within the State of Veracruz.

The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or about 7,700 feet. The Tecolutla Block is a 60-80m gross pay carbonate reservoir on a structural high with proven oil production.

The expectation is that the existing wells at Tecolutla will exceed historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, and expertise to be undertaken by Tonalli.

Last month, International Frontier Resources announced that it received total proceeds of $2,561,045 from the exercise of warrants by members of the Executive and Technical team, Board of Directors and investment community. The Company issued an additional 24,961,880 common shares from its Treasury via the conversion of these warrants to shares.

Mr. Steve Hanson, International Frontier Resources’ President and Chief Executive Officer, stated, “We are pleased to have received a considerable investment in our business from our team, board members and the investment community. This additional capital will allow us to accelerate our business, further our development plans at Tecolutla and participate in future bid rounds in Mexico."

International Frontier Resources Corporation (IFRTF), closed Monday's trading session at $0.127, up 2.17%, on 24,750 volume with 11 trades. The average volume for the last 60 days is 62,566 and the stock's 52-week low/high is $0.0781/$0.2865.

chart

The QualityStocks Company Corner

CytoDyn Inc. (OTCQB: CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

CytoDyn Inc. (OTCQB:CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications in the treatment of HIV, cancer, and inflammatory conditions, announces that Michael A. Klump, President and Chief Executive Officer of Argonne Capital Group, has joined the CytoDyn Board of Directors. Mr. Klump is a significant investor in CytoDyn and brings extensive financing and mergers and acquisition expertise to the CytoDyn Board.

CytoDyn Inc. (OTCQB: CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications. Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.48, up 2.15%, on 147,045 volume with 51 trades. The average volume for the last 60 days is 336,309 and the stock's 52-week low/high is $0.40/$0.836.

Recent News

chart

ChineseInvestors.com (OTCQB: CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that its wholly owned subsidiary, ChineseHempOil.com, Inc. will hold a seminar at its flagship retail store, Chinese Wellness Center, located at 227 West Valley Blvd. #208-B in San Gabriel, CA., covering 'The Health Benefits of Hemp Oil', featuring Chinese Medicine Practitioner Amin Wang.

Founded in 1999, ChineseInvestors.com (OTCQB: CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.6909, up 47.00%, on 1,378,471 volume with 541 trades. The average volume for the last 60 days is 96,895 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

Mineral resource company QMC Quantum Minerals (TSX.V: QMC) (FSE: 3LQ) (OTC: QMCQF) continues to expand its land package located in one of the world’s most mining-friendly areas in the prolific mining region of Manitoba, Canada. To view the full article, visit: http://nnw.fm/9VJim.

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.3065, up 15.75%, on 250,742 volume with 96 trades. The average volume for the last 60 days is 114,433 and the stock's 52-week low/high is $0.078/$1.46.

Recent News

chart

BLOCKStrain Technology Corp. (TSX-V: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

BLOCKStrain Technology (TSX.V: DNAX) is reaching key milestones in the on-boarding of Licensed Producers (“LPs”) and testing partners for use of its disruptive seed-to-sale platform. To view the full article, visit: http://nnw.fm/rXW05.

BLOCKStrain Technology Corp. (TSX-V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.19, up 5.56%, 81,000 volume. The stock's 52-week low/high is $0.105/$1.20.

Recent News

chart

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” In this week’s episode, SinglePoint CEO Greg Lambrecht discussed the company’s Form 10 and increased revenues in the first quarter. Lambrecht also highlighted the company’s enhanced acquisition targets. "We're really interested in doing larger acquisitions, somewhere between five and ten million," SinglePoint CEO Greg Lambrecht stated in the interview. To view the full interview, visit: http://cnw.fm/E5oEw. To view the full press release, visit: http://cnw.fm/wWv28.

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0385, up 11.63%, on 3,368,112 volume with 186 trades. The average volume for the last 60 days is 6,634,472 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News

chart

GreenBox POS, LLC (OTCQB: GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC  (USOTC: GRBX), ("GreenBox", "the Company") is pleased to announce the acquisition of Sky Mids Technologies ("Sky"), development and processing Corporation. Sky's transactional platform specializes in robust and secure payments processing. The company has been utilizing GreenBox's revolutionary payments system, QuickCard, as its main payments infrastructure for some time and the experience has been exceptional for both companies.

GreenBox POS, LLC (OTCQB: GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $1.30, up 10.17%, on 47,494 volume with 55 trades. The average volume for the last 60 days is 47,072 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

Earth Science Tech, Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Biotechnology company Earth Science Tech (OTC: ETST) is expanding its product line of dark chocolates in light of budding growth in the edibles market. Launch is expected in the third quarter of 2018 (http://cnw.fm/qiT1v).” To view the full article, visit: http://cnw.fm/3V6aB.

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.7689, up 2.55%, on 3,100 volume with 10 trades. The average volume for the last 60 days is 10,435 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Focused on operating the first-ever environmentally friendly oil sands mining facility, fully integrated oil and gas company Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF) recently announced that it has finalized continuity testing at its Asphalt Ridge facility in Utah’s Uintah Basin and is making final arrangements for continuous operations and marketing activities (http://nnw.fm/xHq4x).

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.39, up 0.73%, on 753,029 volume with 620 trades. The average volume for the last 60 days is 327,733 and the stock's 52-week low/high is $0.28/$1.8892.

Recent News

chart

Pacific Software, Inc. (OTC: PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Emerging development technology corporation Pacific Software (OTC: PFSF) today announced that it has signed a definitive agreement with Cobalt 47 Technologies LTD, a spin-off of KBQuest Group, to commence construction of its proprietary e-commerce trade platform. To view the full press release, visit: http://ccw.fm/2VDmz.

Pacific Software, Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

Agriculture
For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Cannabis
Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.25, even for the day. The average volume for the last 60 days is 55 and the stock's 52-week low/high is $4.00/$5.25.

Recent News

chart

Sharing Services, Inc. (OTC: SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services, Inc. (OTC: SHRV) today announces the appointment of Keith Halls as the president and chief operating officer of its wholly owned subsidiary, Elepreneur, LLC, effective immediately.

Sharing Services, Inc. (OTC: SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.33, even for the day. The average volume for the last 60 days is 22,914 and the stock's 52-week low/high is $0.125/$1.06.

Recent News

chart

Cannabis Strategic Ventures, Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (OTC: NUGS) has pursued its mission to foster legalized cannabis industry value-adds by building a portfolio of vertically integrated companies, and now the company is preparing to uplist on the public markets by refocusing its efforts on bringing its financial reporting up to par.

Cannabis Strategic Ventures, Inc. (OTC: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.65, off by 11.76%, on 34,275 volume with 105 trades. The average volume for the last 60 days is 31,222 and the stock's 52-week low/high is $0.031/$7.13.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the US licensed medical cannabis industry, has advanced US $1.25 million, the initial tranche of capital, to its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California. Also today, NetworkNewsWire released a report on the company detailing how FNNZF continues to gain momentum as it invests in top-tier cannabis-related companies.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1788, off by 9.58%, on 8,601 volume with 5 trades. The average volume for the last 60 days is 46,108 and the stock's 52-week low/high is $0.10/$0.8736.

Recent News

chart

Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

CryptoNewsAudio announces the Audio Press Release (APR) titled "ATMs Provide Potential Route for Cryptocurrency into the Mainstream," featuring Virtual Crypto Technologies Inc. (OTCQB: VRCP). To hear the CryptoNewsAudio version, visit http://ccw.fm/w8sjL. To view the full editorial, visit http://ccw.fm/bpH7c.

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website, www.virtual-crypto.com, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.10, off by 19.03%, on 161,982 volume with 32 trades. The average volume for the last 60 days is 31,323 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.